|
11. |
Arterial Stiffness and Kidney Function |
|
Hypertension: Journal of The American Heart Association,
Volume 43,
Issue 2,
2004,
Page 163-168
Michel Safar,
Gérard London,
Gérard Plante,
Preview
|
PDF (84KB)
|
|
摘要:
Abstract—The vascular hallmark of subjects with end-stage renal disease undergoing hemodialysis is increased aortic stiffness, a phenomenon independent of mean arterial blood pressure, wall stress, and standard cardiovascular risk factors such as plasma glucose, cholesterol, obesity, and smoking. These observations suggest that subtle links might associate arterial stiffness and kidney function in normotensive and hypertensive populations. Recently, aortic pulse wave velocity and creatinine clearance have been shown to be statistically associated in subjects with plasma creatinine ≤130 &mgr;mol/L, again independently of mean arterial blood pressure and classical cardiovascular risk factors. This association was even shown to predominate in subjects younger than age 55 years. In addition, acceleration of aortic pulse wave velocity with age was more important in these subjects than in untreated normotensive control individuals, and the phenomenon was consistently predicted by baseline plasma creatinine values. Among all antihypertensive drugs, angiotensin-converting enzyme inhibitors only were shown to exhibit a significant and independent effect on aortic stiffness. The use of these drugs was significantly associated with improvement of large aortic stiffness in subjects treated for hypertension. In conclusion, increased stiffness of central arteries is independently associated with reduced creatinine clearance in subjects with mild to severe renal insufficiency, indicating that kidney diseases may interact not only with small but also with large conduit arteries, independently of age, blood pressure level, and classical cardiovascular risk factors. Whether sodium, divalent ionic species (calcium, phosphates), and the renin-angiotensin-aldosterone system play a role in such alterations remains to be elucidated.
ISSN:0194-911X
出版商:OVID
年代:2004
数据来源: OVID
|
12. |
Sympathetic Augmentation in HypertensionRole of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation |
|
Hypertension: Journal of The American Heart Association,
Volume 43,
Issue 2,
2004,
Page 169-175
Markus Schlaich,
Elisabeth Lambert,
David Kaye,
Zygmunt Krozowski,
Duncan Campbell,
Gavin Lambert,
Jacqui Hastings,
Anuradha Aggarwal,
Murray Esler,
Preview
|
PDF (125KB)
|
|
摘要:
Abstract—There is growing evidence that essential hypertension is commonly neurogenic and is initiated and sustained by sympathetic nervous system overactivity. Potential mechanisms include increased central sympathetic outflow, altered norepinephrine (NE) neuronal reuptake, diminished arterial baroreflex dampening of sympathetic nerve traffic, and sympathetic neuromodulation by angiotensin II. To address this issue, we used microneurography and radiotracer dilution methodology to measure regional sympathetic activity in 22 hypertensive patients and 11 normotensive control subjects. The NE transport inhibitor desipramine was infused to directly assess the potential role of impaired neuronal NE reuptake. To evaluate possible angiotensin sympathetic neuromodulation, the relation of arterial and coronary sinus plasma concentrations of angiotensin II to sympathetic activity was investigated. Hypertensive patients displayed increased muscle sympathetic nerve activity and elevated total systemic, cardiac, and renal NE spillover. Cardiac neuronal NE reuptake was decreased in hypertensive subjects. In response to desipramine, both the reduction of fractional transcardiac3[H]NE extraction and the increase in cardiac NE spillover were less pronounced in hypertensive patients. DNA sequencing analysis of the NE transporter gene revealed no mutations that could account for reduced transporter activity. Arterial baroreflex control of sympathetic nerve traffic was not diminished in hypertensive subjects. Angiotensin II plasma concentrations were similar in both groups and were not related to indexes of sympathetic activation. Increased rates of sympathetic nerve firing and reduced neuronal NE reuptake both contribute to sympathetic activation in hypertension, whereas a role for dampened arterial baroreflex restraint on sympathetic nerve traffic and a peripheral neuromodulating influence of angiotensin II appear to be excluded.
ISSN:0194-911X
出版商:OVID
年代:2004
数据来源: OVID
|
13. |
Increased Central Artery Stiffness in Impaired Glucose Metabolism and Type 2 DiabetesThe Hoorn Study |
|
Hypertension: Journal of The American Heart Association,
Volume 43,
Issue 2,
2004,
Page 176-181
Miranda Schram,
Ronald Henry,
Rob van Dijk,
Piet Kostense,
Jacqueline Dekker,
Giel Nijpels,
Robert Heine,
Lex Bouter,
Nico Westerhof,
Coen Stehouwer,
Preview
|
PDF (82KB)
|
|
摘要:
Abstract—Impaired glucose metabolism (IGM) and type 2 diabetes (DM-2) are associated with high cardiovascular disease risk. Increases in peripheral and central artery stiffness may represent pathophysiologic pathways through which glucose tolerance status leads to cardiovascular disease. Peripheral artery stiffness increases with deteriorating glucose tolerance status, whereas this trend remains unclear for central artery stiffness. Therefore, we investigated the associations between glucose tolerance status and estimates of central arterial stiffness. We performed a population-based study of 619 individuals (normal glucose metabolism, n=261; IGM, n=170; and DM-2, n=188) and assessed central artery stiffness by measuring total systemic arterial compliance, aortic pressure augmentation index, and carotid-femoral transit time. After adjustment for sex, age, heart rate, height, body mass index, and mean arterial pressure, DM-2 was associated with decreased total systemic arterial compliance, increased aortic augmentation index, and decreased carotid-femoral transit time. IGM was borderline significantly associated with decreased total systemic arterial compliance. Respective regression coefficients (95% confidence intervals) for IGM and DM-2 compared with normal glucose metabolism were −0.05 (−0.11 to 0.01) and −0.13 (−0.19 to −0.07) mL/mm Hg for total systemic arterial compliance; 1.1 (−0.2 to 2.5) and 1.6 (0.2 to 3.0) percentage points for aortic augmentation index; and −0.85 (−5.20 to 3.49) and −4.95 (−9.41 to −0.48) ms for carotid-femoral transit time. IGM and DM-2 are associated with increased central artery stiffness, which is more pronounced in DM-2. Deteriorating glucose tolerance is associated with increased central and peripheral arterial stiffness, which may partly explain why both DM-2 and IGM are associated with increased cardiovascular risk.
ISSN:0194-911X
出版商:OVID
年代:2004
数据来源: OVID
|
14. |
Short Telomeres Are Associated With Increased Carotid Atherosclerosis in Hypertensive Subjects |
|
Hypertension: Journal of The American Heart Association,
Volume 43,
Issue 2,
2004,
Page 182-185
Athanase Benetos,
Jeffrey Gardner,
Mahmoud Zureik,
Carlos Labat,
Lu Xiaobin,
Chris Adamopoulos,
Mohamed Temmar,
Kathryn Bean,
Frédérique Thomas,
Abraham Aviv,
Preview
|
PDF (103KB)
|
|
摘要:
Abstract—Recent studies have shown that individuals with shorter telomeres present a higher prevalence of arterial lesions and higher risk of cardiovascular disease mortality. As a group, patients with high blood pressure are at an increased risk for cardiovascular diseases. However, some hypertensive patients are more prone than others to atherosclerotic lesions. The main objective of this study was to examine the relationship between telomere length, as expressed in white blood cells, and carotid artery atherosclerotic plaques in hypertensive males. Data from 163 treated hypertensive men who were volunteers for a free medical examination were analyzed. Extracranial carotid plaques were assessed with B-mode ultrasound. Telomere length was measured from DNA samples extracted from white blood cells. The results of this study show that telomere length was shorter in hypertensive men with carotid artery plaques versus hypertensive men without plaques (8.17±0.07 kb versus 8.46±0.07 kb;P<0.01). Multivariate analysis showed that in addition to age, telomere length was a significant predictor of the presence of carotid artery plaques. The findings from this study suggest that in the presence of chronic hypertension, which is a major risk factor for atherosclerotic lesions, shorter telomere length in white blood cells is associated with an increased predilection to carotid artery atherosclerosis.
ISSN:0194-911X
出版商:OVID
年代:2004
数据来源: OVID
|
15. |
Relationship Between Carbamoyl-Phosphate Synthetase Genotype and Systemic Vascular Function |
|
Hypertension: Journal of The American Heart Association,
Volume 43,
Issue 2,
2004,
Page 186-191
Marshall Summar,
James Gainer,
Mias Pretorius,
Hector Malave,
Stephanie Harris,
Lynn Hall,
Alec Weisberg,
Douglas Vaughan,
Brian Christman,
Nancy Brown,
Preview
|
PDF (70KB)
|
|
摘要:
Abstract—Endothelial cells can convert l-citrulline to l-arginine, the precursor of nitric oxide. The present study tests the hypothesis that a C-to-A nucleotide transversion (T1405N) in the gene-encoding carbamoyl-phosphate synthetase 1, the enzyme catalyzing the rate-limiting step in l-citrulline formation, influences nitric oxide metabolite concentrations or nitric oxide-mediated vasodilation in humans. Bradykinin (100, 200, and 400 ng/min) was infused via brachial artery in 106 (CC:AC:AA=40:54:12) healthy subjects. Sodium nitroprusside (1.6, 3.2, and 6.4 &mgr;g/min) was also infused in 87 (CC:AC:AA=31:46:10) subjects. Forearm blood flow was measured by plethysmography and blood samples were collected for tissue-type plasminogen activator antigen, nitric oxide metabolites, and cyclic GMP. There was a significant relationship between carbamoyl-phosphate synthetase 1 genotype and nitric oxide metabolites, such that nitric oxide metabolite concentrations were highest in individuals homozygous for the C allele (mean±SD, 14.0±8.5 &mgr;mol/L), lowest in individuals homozygous for the A allele (9.1±3.1 &mgr;mol/L), and intermediate (11.8±6.6 &mgr;mol/L) in heterozygotes (P=0.036). There was a significant effect of carbamoyl-phosphate synthetase 1 genotype on forearm blood flow during bradykinin (P=0.028), such that the vasodilator response was greatest in C allele homozygotes (22.2±9.1 mL/min/100 mL at 400 ng/min), least in A allele homozygotes (13.6±6.2 mL/min/100 mL), and intermediate (19.4±10.7 mL/min/100 mL) in heterozygotes. Similarly, carbamoyl-phosphate synthetase 1 genotype influenced forearm blood flow during nitroprusside (maximal flow 19.2±8.3, 18.1±8.3, and 11.5±4.9 mL/min/100 mL in the CC:AC:AA groups, respectively;P=0.022). In contrast, there was no effect of carbamoyl-phosphate synthetase 1 genotype on the nitric oxide–independent tissue-type plasminogen activator response to bradykinin (P=0.943). These data indicate that a polymorphism in the gene encoding carbamoyl-phosphate synthetase 1 influences nitric oxide production as well as vascular smooth muscle reactivity.
ISSN:0194-911X
出版商:OVID
年代:2004
数据来源: OVID
|
16. |
Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension |
|
Hypertension: Journal of The American Heart Association,
Volume 43,
Issue 2,
2004,
Page 192-197
Frank Scheer,
Gert Van Montfrans,
Eus van Someren,
Gideon Mairuhu,
Ruud Buijs,
Preview
|
PDF (157KB)
|
|
摘要:
Abstract—Patients with essential hypertension have disturbed autonomic cardiovascular regulation and circadian pacemaker function. Recently, the biological clock was shown to be involved in autonomic cardiovascular regulation. Our objective was to determine whether enhancement of the functioning of the biological clock by repeated nighttime melatonin intake might reduce ambulatory blood pressure in patients with essential hypertension. We conducted a randomized, double-blind, placebo-controlled, crossover trial in 16 men with untreated essential hypertension to investigate the influence of acute (single) and repeated (daily for 3 weeks) oral melatonin (2.5 mg) intake 1 hour before sleep on 24-hour ambulatory blood pressure and actigraphic estimates of sleep quality. Repeated melatonin intake reduced systolic and diastolic blood pressure during sleep by 6 and 4 mm Hg, respectively. The treatment did not affect heart rate. The day–night amplitudes of the rhythms in systolic and diastolic blood pressures were increased by 15% and 25%, respectively. A single dose of melatonin had no effect on blood pressure. Repeated (but not acute) melatonin also improved sleep. Improvements in blood pressure and sleep were statistically unrelated. In patients with essential hypertension, repeated bedtime melatonin intake significantly reduced nocturnal blood pressure. Future studies in larger patient group should be performed to define the characteristics of the patients who would benefit most from melatonin intake. The present study suggests that support of circadian pacemaker function may provide a new strategy in the treatment of essential hypertension.
ISSN:0194-911X
出版商:OVID
年代:2004
数据来源: OVID
|
17. |
Guidelines for Hypertension: Are Quality-Assurance Measures on Target? |
|
Hypertension: Journal of The American Heart Association,
Volume 43,
Issue 2,
2004,
Page 198-202
Gregory Singer,
Munavvar Izhar,
Henry Black,
Preview
|
PDF (235KB)
|
|
摘要:
Abstract—Guideline committees recommend targets of treatment based on trial data on efficacy and effectiveness. Quality-assurance initiatives apply these parameters in the general practice setting. Therefore, targets must be feasible and achievable by the practicing physicians who are judged by these targets as goals for care. We evaluated 437 patients in the Rush University Hypertension Clinic using the Health Employer Data Information Set (HEDIS) measures for 2000 to assess goal achievement in a practice-based setting. We compared guideline achievement of uncomplicated hypertensive and diabetic subjects to standards dictated by HEDIS, the 6th Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI), and the American Diabetic Association (ADA)/National Kidney Foundation (NKF). Overall, 276 (63%) patients achieved SBP goal, with 376 (86%) achieving DBP goal and 358 (59%) achieving both goals. However, in the 20% of patients who were diabetic, only 52% had a BP of <140 mm Hg and <90 mm Hg, whereas only 22% achieved the more stringent goals of JNC VI of <130 mm Hg systolic and <85 mm Hg diastolic and only 15% achieved the ADA/NKF goals of <130 mm Hg systolic and <80 mm Hg diastolic. Although goal was achievable in most uncomplicated hypertension, hypertension in diabetes was more difficult to control, despite being more likely to receive enhanced benefit from effective management. Goal-oriented strategy, especially in diabetic subjects, should be aggressively sought rather than relaxing goals to promote achievement.
ISSN:0194-911X
出版商:OVID
年代:2004
数据来源: OVID
|
18. |
Effect of Birth Weight on Blood Pressure and Body Size in Early Adolescence |
|
Hypertension: Journal of The American Heart Association,
Volume 43,
Issue 2,
2004,
Page 203-207
Bonita Falkner,
Sonia Hulman,
Harvey Kushner,
Preview
|
PDF (78KB)
|
|
摘要:
Abstract—The fetal programming theory that birth weight contributes to blood pressure or body size in later life is examined in this study. A prospective longitudinal study was conducted on subjects who were examined as newborns and prospectively interviewed and re-examined at 11 to 14 years old. Low birth weight (<2500 g) was present in 36% of the sample. The adolescent examination included measurements of blood pressure (BP), both auscultation and oscillometric methods; anthropometrics (height, weight, and body mass index [BMI]); health status; and health behaviors. Data were analyzed on 250 subjects. Correlation coefficients of birth weight with all BP measures were nonsignificant, except for the last auscultated diastolic BP (r=0.19,P<0.01), which had a positive relationship. The simple correlation coefficients of birth weight with adolescent body size were significant and positive for weight and BMI. After multiple linear regression analyses with adjustments for age, Tanner stage, and gestational age, there was no significant effect of birth weight on adolescent weight or BMI. No significant correlations were detected for ponderal index at birth with adolescent measures. This study, which includes a substantial portion of low-birth-weight cases (36%), indicates that birth weight does not correlate negatively with later BP. These results do not support the low-birth-weight theory and indicate that childhood factors that are more proximal have a greater effect on adolescent BP than intrauterine factors.
ISSN:0194-911X
出版商:OVID
年代:2004
数据来源: OVID
|
19. |
Indicators of Fetal Growth Do Not Independently Predict Blood Pressure in 8-Year-Old AustraliansA Prospective Cohort Study |
|
Hypertension: Journal of The American Heart Association,
Volume 43,
Issue 2,
2004,
Page 208-213
Valerie Burke,
Lawrie Beilin,
Kevin Blake,
Dorota Doherty,
Garth Kendall,
John Newnham,
Louis Landau,
Fiona Stanley,
Preview
|
PDF (161KB)
|
|
摘要:
Abstract—Inverse associations between size at birth and blood pressure (BP) in later life are commonly statistically significant only after adjustment for current size, consistent with change in size as the determinant. Few studies have been prospective or have included a range of potential confounders. Using regression models, including maternal and demographic variables, we examined associations between size at birth and BP in Australian children followed from week 16 of gestation to the age of 8 years. BP measurements were available from 1417 children born after 37 weeks gestation without congenital abnormalities. In models adjusted only for sex, the birthweight (BW), birth length, ponderal index, head circumference, chest circumference, abdominal girth, mid-arm circumference, triceps skinfold, placental weight, or BW/placental weight ratio did not significantly predict SBP in 8-year-olds. With adjustment for current size, associations were inverse but not statistically significant (regression coefficients: BW, −1.11; 95% confidence limits [CL], −2.22, 0.01; birth length, −0.25; 95% CL, −0.52, 0.24) and remained nonsignificant after adjustment for confounders. Current weight, height, or body mass index significantly predicted SBP and DBP (P<0.001) with differences of 8/4 mm Hg between upper and lower quartiles; effects were similar in infants with lower and higher BW. These findings are consistent with postnatal change in size as the major determinant of BP in 8-year-olds and are important in the context of the worldwide “epidemic” of obesity in childhood as a likely precursor of increasing rates of hypertension in adults.
ISSN:0194-911X
出版商:OVID
年代:2004
数据来源: OVID
|
20. |
Cardiovascular Risk Factors and Sequelae in Hypertensive Children Identified by Referral Versus School-Based Screening |
|
Hypertension: Journal of The American Heart Association,
Volume 43,
Issue 2,
2004,
Page 214-218
Jonathan Sorof,
Jennifer Turner,
David Martin,
Kathleen Garcia,
Zsolt Garami,
Andrei Alexandrov,
Fiona Wan,
Ronald Portman,
Preview
|
PDF (69KB)
|
|
摘要:
Abstract—To determine whether systematic differences exist between hypertensive children referred for evaluation by primary care providers and children identified through community-based screening, cardiovascular risk factors and surrogate markers of hypertensive injury were compared based on subject source (referral versus screening). Children referred to a hypertension clinic for persistently elevated blood pressure were compared with children identified as hypertensive during school screening of 5102 students in Houston public schools. M-mode echocardiography of the left ventricle was performed and subsequently reviewed by 2 independent sonographers blinded to identifying subject information. Subsets of subjects also underwent carotid artery ultrasound for measurement of intimal-medial thickness, overnight urine collections for microalbuminuria, and fasting serum cholesterol, triglycerides, and glucose. Ninety-seven total subjects (54 screening and 43 referral) met inclusion criteria and had technically adequate echocardiography performed. The prevalence of left ventricular hypertrophy (LVH) was 37%. Referral subjects demonstrated significantly greater left ventricular mass index (38.8 versus 34.2 g/m2.7;P<0.01) and a higher prevalence of LVH (49% versus 28%;P<0.05). Among subjects who underwent carotid ultrasound (n=75), carotid intimal-medial thickness was significantly higher in referral subjects (0.61 versus 0.57,P<0.05). When controlling for BMIzscore, which was significantly higher in referral subjects, systematic differences by subject source did not persist. These findings suggest that hypertensive children who are predominantly overweight, independent of the manner in which patients come to medical attention, will manifest evidence of more severe cardiovascular disease assessed by surrogate markers such as left ventricular mass index or carotid artery intimal medial thickness.
ISSN:0194-911X
出版商:OVID
年代:2004
数据来源: OVID
|
|